{
    "nct_id": "NCT04436029",
    "official_title": "Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy",
    "inclusion_criteria": "* Patients must be 18 years of age or older at the time of enrollment\n* High-risk multiple myeloma patients who complete pre-transplant induction treatment anti- myeloma drug combination (minimum 2 drugs).\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients who are pregnant or lactating.\n* Patients who have any active and uncontrolled infection. No blood cultures are necessary unless clinically indicated.",
    "miscellaneous_criteria": ""
}